The objective of this study was to determine whether small human pancr
eatic adenocarcinomas contain activated c-K-ras as an approach to answ
ering the question of whether c-K-ras mutation is an early change in t
his disease. Eight pancreatic adenocarcinomas in the range 1.2-3 cm we
re analyzed for c-K-ras mutation at codon 12 by amplifying the c-K-ras
gene around codon 12 out of paraffin-embedded tissue sections using t
he polymerase chain reaction. c-K-ras mutations were detected by allel
e-specific oligonucleotide hybridization. Six of the eight small pancr
eatic adenocarcinomas contained mutated c-K-ras at codon 12, position
2, and two of the six tumors had an additional mutation at position 1
of codon 12. Our results indicate that small pancreatic adenocarcinoma
s are similar to large, late-stage pancreatic adenocarcinomas in that
75% of the tumors analyzed contain mutated c-K-ras at codon 12, positi
on 2. These data suggest that c-K-ras mutation occurs early and may th
erefore have a role in initiation of human pancreatic adenocarcinoma.